BACKGROUND: The most commonly encountered dyslipidemia in obese individuals is characterized by a cluster of interrelated plasma lipid and lipoprotein abnormalities including hypertriglyceridemia, low HDL cholesterol values, and increased small, dense LDL cholesterol particles. The aim of this study was to assess the changes in lipid profiles at baseline (pre-operatively) and at follow-up (6, 12, and 18 months) after a laparoscopic Roux-en-Y gastric bypass (LRYGBP). A retrospective observational study was performed involving all patients who consecutively underwent a LRYGBP between January 1, 2007 and December 31, 2009. Fasting lipids sub-fractions (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides) were measured and HOMA-IR calculated pre-operatively and at follow-up post-LRYGBP. Pearson's correlation coefficients were used to assess the relationship between excess weight loss (EWL) and lipid sub-fractions. ANOVA was used to assess the differences between each lipid sub-fraction at various time-points. METHODS: One hundred twenty eight (N = 128) medical charts were reviewed, and those containing data on lipid fractions at the three follow-up time-points were analyzed. One hundred fourteen patients (N = 114), 84 of whom were women (73.7%), were finally included in the study. RESULTS: Total cholesterol, LDL cholesterol, triglycerides, and HOMA-IR were significantly reduced after LRYGBP (P < 0.0005 for all). Inversely, HDL cholesterol disclosed a significant rise (P < 0.0005). Noteworthy significant associations between lipid subfractions and EWL were detected overall (P < 0.0005 for all). A gender effect was found since female patients displayed a milder association than male patients (P < 0.0005). CONCLUSIONS: LRYGBP-induced weight loss improves the lipid profile while reducing insulin resistance, with male patients showing a better profile than female patients.
BACKGROUND: The most commonly encountered dyslipidemia in obese individuals is characterized by a cluster of interrelated plasma lipid and lipoprotein abnormalities including hypertriglyceridemia, low HDL cholesterol values, and increased small, dense LDL cholesterol particles. The aim of this study was to assess the changes in lipid profiles at baseline (pre-operatively) and at follow-up (6, 12, and 18 months) after a laparoscopic Roux-en-Y gastric bypass (LRYGBP). A retrospective observational study was performed involving all patients who consecutively underwent a LRYGBP between January 1, 2007 and December 31, 2009. Fasting lipids sub-fractions (total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides) were measured and HOMA-IR calculated pre-operatively and at follow-up post-LRYGBP. Pearson's correlation coefficients were used to assess the relationship between excess weight loss (EWL) and lipid sub-fractions. ANOVA was used to assess the differences between each lipid sub-fraction at various time-points. METHODS: One hundred twenty eight (N = 128) medical charts were reviewed, and those containing data on lipid fractions at the three follow-up time-points were analyzed. One hundred fourteen patients (N = 114), 84 of whom were women (73.7%), were finally included in the study. RESULTS: Total cholesterol, LDL cholesterol, triglycerides, and HOMA-IR were significantly reduced after LRYGBP (P < 0.0005 for all). Inversely, HDL cholesterol disclosed a significant rise (P < 0.0005). Noteworthy significant associations between lipid subfractions and EWL were detected overall (P < 0.0005 for all). A gender effect was found since female patients displayed a milder association than male patients (P < 0.0005). CONCLUSIONS: LRYGBP-induced weight loss improves the lipid profile while reducing insulin resistance, with male patients showing a better profile than female patients.
Authors: Alain G Bertoni; Denise E Bonds; Susan Steffes; Eric Jackson; Lenore Crago; Aarthi Balasubramanyam; Haiying Chen; David C Goff Journal: Am Heart J Date: 2006-10 Impact factor: 4.749
Authors: Hazel Huang; Takhar Kasumov; Patrick Gatmaitan; Helen M Heneghan; Sangeeta R Kashyap; Philip R Schauer; Stacy A Brethauer; John P Kirwan Journal: Obesity (Silver Spring) Date: 2011-05-05 Impact factor: 5.002
Authors: Jussi Pihlajamäki; Sari Grönlund; Marko Simonen; Pirjo Käkelä; Leena Moilanen; Matti Pääkkönen; Elina Pirinen; Marjukka Kolehmainen; Vesa Kärjä; Sakari Kainulainen; Matti Uusitupa; Esko Alhava; Tatu A Miettinen; Helena Gylling Journal: Metabolism Date: 2009-12-16 Impact factor: 8.694
Authors: Juan Ybarra; Jose M Pou; Francesc Planas; Carlos Ballesta-López; Fernando Echevarne; June H Romeo; Francisco Navarro-López Journal: Endocr Pract Date: 2007-10 Impact factor: 3.443
Authors: J R Burnett; P H Barrett; P Vicini; D B Miller; D E Telford; S J Kleinstiver; M W Huff Journal: Arterioscler Thromb Vasc Biol Date: 1998-12 Impact factor: 8.311
Authors: Matthew J Sharman; William J Kraemer; Dawn M Love; Neva G Avery; Ana L Gómez; Timothy P Scheett; Jeff S Volek Journal: J Nutr Date: 2002-07 Impact factor: 4.798
Authors: Elisenda Climent; David Benaiges; Juan Pedro-Botet; Juana A Flores-Le Roux; Jose M Ramón; Montserrat Villatoro; Laia Fontané; Juan J Chillarón; Albert Goday Journal: Obes Surg Date: 2017-06 Impact factor: 4.129
Authors: Gigliane Cosendey Menegati; Louise Crovesy de Oliveira; Anna Lúcia Andrade Santos; Larissa Cohen; Fernanda Mattos; Laura Maria Carvalho Mendonça; João Régis Ivar Carneiro; Maria Lúcia Fleiuss Farias; Eliane Lopes Rosado Journal: Obes Surg Date: 2016-07 Impact factor: 4.129
Authors: Miguel A Carbajo; Arlett Fong-Hirales; Enrique Luque-de-León; Juan Francisco Molina-Lopez; Javier Ortiz-de-Solórzano Journal: Surg Endosc Date: 2016-06-17 Impact factor: 4.584
Authors: E Griffo; G Nosso; R Lupoli; M Cotugno; G Saldalamacchia; G Vitolo; L Angrisani; P P Cutolo; A A Rivellese; B Capaldo Journal: Obes Surg Date: 2014-05 Impact factor: 4.129